Robert Matthew Strother

A Phase I First-in-Human Study of Enoticumab (REGN421), a Fully Human Delta-like Ligand 4 (Dll4) Monoclonal Antibody in Patients with Advanced Solid Tumors

E. Gabriela Chiorean, Patricia LoRusso, Robert Matthew Strother et al. · Clinical Cancer Research · 2015 · 147 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Literature Based Drug Interaction Prediction with Clinical Assessment Using Electronic Medical Records: Novel Myopathy Associated Drug Interactions

Jon Duke, Xu Han, Zhiping Wang et al. · PLoS Computational Biology · 2012 · 130 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

In Vivo DPP-4 Inhibition to Enhance Engraftment of Single-Unit Cord Blood Transplants in Adults with Hematological Malignancies

Sherif S. Farag, Shivani Srivastava, Steven Messina‐Graham et al. · Stem Cells and Development · 2012 · 120 citations · Full text

Medicine, Hematology, Pharmacology +13

An Open-Label Phase Ib Dose-Escalation Study of TRC105 (Anti-Endoglin Antibody) with Bevacizumab in Patients with Advanced Cancer

Michael S. Gordon, Francisco Robert, Daniela Matei et al. · Clinical Cancer Research · 2014 · 68 citations · Full text

Medicine, Oncology, Pharmacology +17

Pharmacokinetic and anti-cancer properties of high dose ascorbate in solid tumours of ascorbate-dependent mice

Elizabeth J. Campbell, Margreet C.M. Vissers, Christina Wohlrab et al. · Free Radical Biology and Medicine · 2016 · 66 citations

Medicine, Oncology, Pharmacokinetics +11